# Omada Health Inc. (OMDA) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Equipment & Supplies. Price $22.77, market value $1.4 billion.

## Valuation
- **P/E (trailing): 34.0×**. Omada Health Inc. trades at 34.0× trailing earnings. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 40.9×, higher than trailing, so analysts expect earnings to fall.
- **PEG: 0.43**. A PEG of 0.43 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 4.5×**. Each dollar of revenue is priced at 4.5×.
- **Price / book: 5.5×**. The shares trade at 5.5× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: 1.6%** (5-yr avg 2.9%). Free cash flow equals 1.6% of the market value, below its five-year average of 2.9%, so the shares are pricier on cash than usual.
- **Earnings yield: 2.9%**. The inverse of the P/E: 2.9% of the price is earned each year.

## Profitability
- **Gross margin: 68.2%**. Omada Health Inc. keeps 68.2% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: -0.1%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -4.9%**. The company reported a net loss over the last twelve months.
- **Return on equity: -5.6%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -4.8%**. Return on all capital, debt included, is -4.8%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 1.4%**. Each dollar of assets produces 1.4% of profit.

## Growth
- **Revenue growth (1 yr): 53.2%**. Revenue grew 53.2% over the last year.
- **EPS growth (1 yr): 94.3%**. Earnings per share rose 94.3%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.00**. Debt is 0.00 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Omada Health Inc. holds more cash than debt.
- **Altman Z-score: 12.82**. A Z-score of 12.82 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Omada Health Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (12 analysts). 12 analysts cover Omada Health Inc.; the consensus is buy, with an average price target of $28.25 (+24% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -4.0%** (YTD 44.3%, 3-mo 27.0%). The shares are down 4.0% over twelve months including dividends.
- **From 52-week high: -15.4%** (121.5% above the low). Trading 15% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 48**. An RSI of 48 is neutral.
- **Beta (1 yr): 1.23** (volatility 59%). Beta of 1.23 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=OMDA · Page: https://foliofundamentals.com/stocks/omda

Not investment advice.